Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 114

Results For "NHA"

1578 News Found

PM-JAY public dashboard gets revamped with new features
News | June 07, 2022

PM-JAY public dashboard gets revamped with new features

The dashboard will serve as a single source of truth for public and PM-JAY stakeholders providing comprehensive view of scheme’s progress


Lonza launches new non-endotoxin pyrogen detection system
News | June 07, 2022

Lonza launches new non-endotoxin pyrogen detection system

The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics


FDA publishes ANP’s polymeric drug excipient DMF
Drug Approval | June 06, 2022

FDA publishes ANP’s polymeric drug excipient DMF

The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.


Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
News | June 04, 2022

Indian pharma market to grow at a CAGR of 12.3% to US$130 bn

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030


Fortis Healthcare opens Healthcare Information Centre at Tirupati
Healthcare | June 04, 2022

Fortis Healthcare opens Healthcare Information Centre at Tirupati

The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.


How would AI change manufacturing & packaging processes?
News | June 03, 2022

How would AI change manufacturing & packaging processes?

These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022


Digitalization of pharma labs will help in better decision making: Experts
Digitisation | June 02, 2022

Digitalization of pharma labs will help in better decision making: Experts

Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth


US FDA accepts new drug application filed by Avillion for AstraZeneca's PT027
Drug Approval | June 01, 2022

US FDA accepts new drug application filed by Avillion for AstraZeneca's PT027

Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study